| 1 | Added value of FDG-PET for detection of progressive supranuclear palsy | 4.2 | 8 | Citations (PDF) |
| 2 | An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s disease | 2.0 | 0 | Citations (PDF) |
| 3 | Positron Emission Tomography
Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach | 3.2 | 3 | Citations (PDF) |
| 4 | Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder | 10.8 | 17 | Citations (PDF) |
| 5 | Adaptive and pathological connectivity responses in Parkinson’s disease brain networks | 1.9 | 20 | Citations (PDF) |
| 6 | Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses | 1.9 | 16 | Citations (PDF) |
| 7 | A Network Imaging Biomarker of X‐Linked Dystonia‐Parkinsonism | 4.6 | 9 | Citations (PDF) |
| 8 | Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern | 1.6 | 3 | Citations (PDF) |
| 9 | Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease | 3.9 | 5 | Citations (PDF) |
| 10 | Parkinson’s disease progression: Increasing expression of an invariant common core subnetwork | 2.2 | 9 | Citations (PDF) |
| 11 | A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism | 2.7 | 22 | Citations (PDF) |
| 12 | The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease | 20.8 | 304 | Citations (PDF) |
| 13 | Prospective F-18 FDOPA PET Imaging Study in Human PD | 1.0 | 17 | Citations (PDF) |
| 14 | In utero exposure to maternal anti–aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring | 8.7 | 19 | Citations (PDF) |
| 15 | Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy | 0.5 | 21 | Citations (PDF) |
| 16 | Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography | 2.2 | 25 | Citations (PDF) |
| 17 | Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients | 2.7 | 26 | Citations (PDF) |
| 18 | Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease | 3.2 | 19 | Citations (PDF) |
| 19 | Automated differential diagnosis of dementia syndromes using FDG PET and machine learning | 2.7 | 32 | Citations (PDF) |
| 20 | Functional brain networks in the evaluation of patients with neurodegenerative disorders | 18.3 | 105 | Citations (PDF) |
| 21 | Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease | 3.0 | 22 | Citations (PDF) |
| 22 | Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration | 0.7 | 17 | Citations (PDF) |
| 23 | Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia | 2.7 | 16 | Citations (PDF) |
| 24 | Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders | 3.8 | 18 | Citations (PDF) |
| 25 | Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism | 4.0 | 22 | Citations (PDF) |
| 26 | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease | 4.4 | 27 | Citations (PDF) |
| 27 | Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography Study | 1.6 | 5 | Citations (PDF) |
| 28 | Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network | 1.9 | 32 | Citations (PDF) |
| 29 | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values | 1.5 | 6 | Citations (PDF) |
| 30 | Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study | 0.7 | 17 | Citations (PDF) |
| 31 | Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia | 4.0 | 56 | Citations (PDF) |
| 32 | Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease | 3.2 | 30 | Citations (PDF) |
| 33 | LRRK2 and GBA Variants Exert Distinct Influences on Parkinson’s Disease-Specific Metabolic Networks | 1.9 | 53 | Citations (PDF) |
| 34 | Unique white matter structural connectivity in early-stage drug-naive Parkinson disease | 0.7 | 41 | Citations (PDF) |
| 35 | GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes | 3.2 | 77 | Citations (PDF) |
| 36 | GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop | 2.2 | 121 | Citations (PDF) |
| 37 | Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach | 4.0 | 38 | Citations (PDF) |
| 38 | Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts | 2.2 | 25 | Citations (PDF) |
| 39 | Hemispheric Network Expression in Parkinson’s Disease: Relationship to Dopaminergic Asymmetries | 2.2 | 16 | Citations (PDF) |
| 40 | Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia | 4.0 | 67 | Citations (PDF) |
| 41 | Network Structure and Function in Parkinson’s Disease | 1.9 | 44 | Citations (PDF) |
| 42 | Dopamine modulates striatal response to reward and punishment in patients with Parkinson’s disease | 1.2 | 9 | Citations (PDF) |
| 43 | Switching Language Modes: Complementary Brain Patterns for Formulaic and Propositional Language | 1.4 | 47 | Citations (PDF) |
| 44 | Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts | 2.3 | 51 | Citations (PDF) |
| 45 | Global and multi-focal changes in cerebral blood flow during subthalamic nucleus stimulation in Parkinson’s disease | 3.1 | 9 | Citations (PDF) |
| 46 | Disruption of network for visual perception of natural motion in primary dystonia | 2.3 | 8 | Citations (PDF) |
| 47 | IC‐P‐045: SIMILAR METABOLIC BRAIN CHARACTERISTICS OF DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA | 0.8 | 0 | Citations (PDF) |
| 48 | IC‐P‐073: ABNORMAL METABOLIC NETWORK ACTIVITY IN PARKINSON'S DISEASE WITH GBA VARIANTS | 0.8 | 0 | Citations (PDF) |
| 49 | Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity | 8.7 | 90 | Citations (PDF) |
| 50 | P3‐364: SIMILAR METABOLIC BRAIN CHARACTERISTICS OF DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA | 0.8 | 0 | Citations (PDF) |
| 51 | A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia | 1.5 | 20 | Citations (PDF) |
| 52 | The Age-Related Perfusion Pattern Measured With Arterial Spin Labeling MRI in Healthy Subjects | 2.7 | 66 | Citations (PDF) |
| 53 | The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson’s disease | 0.5 | 11 | Citations (PDF) |
| 54 | Network imaging biomarkers: insights and clinical applications in Parkinson's disease | 13.7 | 159 | Citations (PDF) |
| 55 | Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations | 3.1 | 65 | Citations (PDF) |
| 56 | Parkinson's disease-related network topographies characterized with resting state functional MRI | 2.3 | 77 | Citations (PDF) |
| 57 | Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers | 3.2 | 109 | Citations (PDF) |
| 58 | The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson’s disease | 0.5 | 29 | Citations (PDF) |
| 59 | Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample | 1.4 | 73 | Citations (PDF) |
| 60 | [IC‐P‐035]: MONITORING THE PROGRESSION OF DEMENTIA USING FDG‐PET BRAIN IMAGING AND NETWORK ANALYSIS: ROLE OF THE ALZHEIMER's DISEASE‐RELATED PATTERN | 0.8 | 0 | Citations (PDF) |
| 61 | Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia | 2.7 | 43 | Citations (PDF) |
| 62 | [P1–391]: MONITORING THE PROGRESSION OF DEMENTIA USING FGD‐PET BRAIN IMAGING AND NETWORK ANALYSIS: ROLE OF THE ALZHEIMER's DISEASE‐RELATED PATTERN | 0.8 | 1 | Citations (PDF) |
| 63 | Imbalance of the direct and indirect pathways in focal dystonia: a balanced viewBrain, 2017, 140, 3075-3077 | 5.9 | 13 | Citations (PDF) |
| 64 | Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease | 3.7 | 114 | Citations (PDF) |
| 65 | Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia | 3.7 | 19 | Citations (PDF) |
| 66 | Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease | 1.5 | 9 | Citations (PDF) |
| 67 | Characteristic metabolic brain pattern in Slovenian Parkinson's disease patients | 2.0 | 0 | Citations (PDF) |
| 68 | Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation | 4.0 | 19 | Citations (PDF) |
| 69 | Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases | 0.7 | 87 | Citations (PDF) |
| 70 | Knowledge gaps and research recommendations for essential tremor | 2.0 | 56 | Citations (PDF) |
| 71 | Association of
GBA
Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease | 12.1 | 227 | Citations (PDF) |
| 72 | Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model | 3.5 | 14 | Citations (PDF) |
| 73 | Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study | 4.0 | 96 | Citations (PDF) |
| 74 | Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia | 1.9 | 233 | Citations (PDF) |
| 75 | Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia | 3.7 | 36 | Citations (PDF) |
| 76 | Dopaminergic correlates of metabolic network activity in Parkinson's disease | 2.3 | 87 | Citations (PDF) |
| 77 | Abnormal Metabolic Pattern Associated with Cognitive Impairment in Parkinson'S Disease: A Validation Study | 3.1 | 58 | Citations (PDF) |
| 78 | Parkinson's Disease—Related Spatial Covariance Pattern Identified with Resting-State Functional MRI | 3.1 | 51 | Citations (PDF) |
| 79 | Metabolic resting-state brain networks in health and disease | 5.2 | 102 | Citations (PDF) |
| 80 | Thalamocortical Connectivity Correlates with Phenotypic Variability in Dystonia | 1.9 | 44 | Citations (PDF) |
| 81 | Effects of levodopa on regional cerebral metabolism and blood flow | 3.2 | 45 | Citations (PDF) |
| 82 | Human Radiation Dosimetry for the N-Methyl-d-Aspartate Receptor Radioligand 11C-CNS5161 | 4.0 | 10 | Citations (PDF) |
| 83 | The visual perception of natural motion: abnormal task-related neural activity in DYT1 dystoniaBrain, 2015, 138, 3598-3609 | 5.9 | 19 | Citations (PDF) |
| 84 | Assessing Cerebral Glucose Metabolism in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder | 3.1 | 64 | Citations (PDF) |
| 85 | 18FDG-microPET and MR DTI findings in Tor1a+/− heterozygous knock-out mice | 3.5 | 16 | Citations (PDF) |
| 86 | Abnormal activation of motion perception-related brain networks in primary dystonia (P4.326) | 0.7 | 1 | Citations (PDF) |
| 87 | Quantifying Significance of Topographical Similarities of Disease-Related Brain Metabolic Patterns | 1.5 | 29 | Citations (PDF) |
| 88 | Regional Brain Metabolism in a Murine Systemic Lupus Erythematosus Model | 3.1 | 32 | Citations (PDF) |
| 89 | Abnormal metabolic network activity in REM sleep behavior disorder | 0.7 | 170 | Citations (PDF) |
| 90 | Characterization of disease‐related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners | 2.3 | 46 | Citations (PDF) |
| 91 | A disease-specific metabolic brain network associated with corticobasal degenerationBrain, 2014, 137, 3036-3046 | 5.9 | 123 | Citations (PDF) |
| 92 | The Utility of Neuroimaging in the Differential Diagnosis of Parkinsonian Syndromes | 1.2 | 32 | Citations (PDF) |
| 93 | Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorderBrain, 2014, 137, 3122-3128 | 5.9 | 154 | Citations (PDF) |
| 94 | Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease | 2.9 | 41 | Citations (PDF) |
| 95 | The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging | 1.4 | 27 | Citations (PDF) |
| 96 | Network modulation following sham surgery in Parkinson’s disease | 6.6 | 91 | Citations (PDF) |
| 97 | Understanding the Anatomy of Dystonia: Determinants of Penetrance and Phenotype | 4.0 | 17 | Citations (PDF) |
| 98 | Parkinson's disease cognitive network correlates with caudate dopamine | 3.0 | 99 | Citations (PDF) |
| 99 | Parkinson's Disease: Increased Motor Network Activity in the Absence of Movement | 2.3 | 37 | Citations (PDF) |
| 100 | Metabolic Imaging of Bilateral Anterior Capsulotomy in Refractory Obsessive Compulsive Disorder: an FDG PET Study | 3.1 | 57 | Citations (PDF) |
| 101 | White matter changes in primary dystonia determined by 2D distribution analysis of diffusion tensor images | 2.6 | 11 | Citations (PDF) |
| 102 | Early registration of diffusion tensor images for group tractography of dystonia patients | 2.6 | 14 | Citations (PDF) |
| 103 | Metabolic changes in
DYT11
myoclonus-dystonia | 0.7 | 72 | Citations (PDF) |
| 104 | Metabolic network as a progression biomarker of premanifest Huntington’s disease | 6.6 | 119 | Citations (PDF) |
| 105 | Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data | 0.2 | 47 | Citations (PDF) |
| 106 | Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data | 0.2 | 7 | Citations (PDF) |
| 107 | Parkinson's Disease Metabolic Network Predicts Phenoconversion in Patients with Idiopathic REM Sleep Behavior Disorder (S19.004) | 0.7 | 0 | Citations (PDF) |
| 108 | Therapeutic High-Frequency Stimulation of the Subthalamic Nucleus in Parkinson's Disease Produces Global Increases in Cerebral Blood Flow | 3.1 | 22 | Citations (PDF) |
| 109 | Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism | 3.1 | 35 | Citations (PDF) |
| 110 | Functional brain networks in movement disorders | 2.4 | 36 | Citations (PDF) |
| 111 | Correlation of Laparoscopic Experience With Differential Functional Brain Activation | 2.4 | 8 | Citations (PDF) |
| 112 | Network correlates of disease severity in multiple system atrophy | 0.7 | 60 | Citations (PDF) |
| 113 | Improved Sequence Learning with Subthalamic Nucleus Deep Brain Stimulation: Evidence for Treatment-Specific Network Modulation | 2.3 | 63 | Citations (PDF) |
| 114 | Functional Neuroimaging in Parkinson's Disease | 2.9 | 77 | Citations (PDF) |
| 115 | Functional brain imaging of cognitive dysfunction in Parkinson's disease | 4.2 | 46 | Citations (PDF) |
| 116 | Metabolic brain networks in translational neurology: Concepts and applications | 4.6 | 152 | Citations (PDF) |
| 117 | Functional brain networks and abnormal connectivity in the movement disorders | 3.0 | 114 | Citations (PDF) |
| 118 | Abnormal network topographies and changes in global activity: Absence of a causal relationship | 3.0 | 14 | Citations (PDF) |
| 119 | The Relationship Between the Acute Cerebral Metabolic Response to Citalopram and Chronic Citalopram Treatment Outcome | 1.6 | 16 | Citations (PDF) |
| 120 | Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects | 3.0 | 259 | Citations (PDF) |
| 121 | Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues | 3.0 | 183 | Citations (PDF) |
| 122 | Basal ganglia and kinematics modulation: Insights from Parkinson’s and Huntington’s diseases | 2.0 | 14 | Citations (PDF) |
| 123 | Dopamine cell transplantation in Parkinson's disease: challenge and perspective | 3.3 | 16 | Citations (PDF) |
| 124 | Differences in Regional Brain Activation Patterns Assessed by Functional Magnetic Resonance Imaging in Patients with Systemic Lupus Erythematosus Stratified by Disease Duration | 4.3 | 44 | Citations (PDF) |
| 125 | Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging | 3.5 | 173 | Citations (PDF) |
| 126 | Milestones in neuroimaging | 3.2 | 9 | Citations (PDF) |
| 127 | Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression | 2.3 | 51 | Citations (PDF) |
| 128 | Impaired sequence learning in dystonia mutation carriers: a genotypic effectBrain, 2011, 134, 1416-1427 | 5.9 | 80 | Citations (PDF) |
| 129 | Abnormal metabolic brain networks in Tourette syndrome | 0.7 | 90 | Citations (PDF) |
| 130 | Brain networks in Huntington disease | 6.6 | 74 | Citations (PDF) |
| 131 | Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice | 5.2 | 121 | Citations (PDF) |
| 132 | Network correlates of the cognitive response to levodopa in Parkinson disease | 0.7 | 67 | Citations (PDF) |
| 133 | Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis | 13.7 | 346 | Citations (PDF) |
| 134 | Early Parkinson's disease: Longitudinal changes in brain activity during sequence learning | 3.5 | 46 | Citations (PDF) |
| 135 | Imaging essential tremor | 3.2 | 83 | Citations (PDF) |
| 136 | Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes | 4.0 | 182 | Citations (PDF) |
| 137 | Functional Imaging of Cognitive Impairment in Parkinson's Disease | 1.4 | 4 | Citations (PDF) |
| 138 | Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease | 2.3 | 192 | Citations (PDF) |
| 139 | Increased sensorimotor network activity in DYT1 dystonia: a functional imaging studyBrain, 2010, 133, 690-700 | 5.9 | 95 | Citations (PDF) |
| 140 | 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease | 1.8 | 47 | Citations (PDF) |
| 141 | Cerebellothalamocortical Connectivity Regulates Penetrance in Dystonia | 2.3 | 305 | Citations (PDF) |
| 142 | Mom and me | 0.7 | 1 | Citations (PDF) |
| 143 | Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's diseaseBrain, 2009, 132, 392-401 | 5.9 | 39 | Citations (PDF) |
| 144 | Abnormal striatal and thalamic dopamine neurotransmission | 0.7 | 121 | Citations (PDF) |
| 145 | Network biomarkers for the diagnosis and treatment of movement disorders | 3.5 | 36 | Citations (PDF) |
| 146 | Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease | 3.2 | 40 | Citations (PDF) |
| 147 | Metabolic brain networks in neurodegenerative disorders: a functional imaging approach | 6.8 | 398 | Citations (PDF) |
| 148 | Abnormal structure-function relationships in hereditary dystonia | 1.8 | 133 | Citations (PDF) |
| 149 | Seizure propagation in a patient with musicogenic epilepsy | 1.4 | 38 | Citations (PDF) |
| 150 | Learning and consolidation of visuo-motor adaptation in Parkinson's disease | 2.0 | 117 | Citations (PDF) |
| 151 | Serotonin Modulation of Cerebral Glucose Metabolism in Depressed Older Adults | 3.8 | 50 | Citations (PDF) |
| 152 | Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features | 3.0 | 112 | Citations (PDF) |
| 153 | Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography | 1.8 | 77 | Citations (PDF) |
| 154 | Microstructural white matter changes in primary torsion dystonia | 3.2 | 108 | Citations (PDF) |
| 155 | Abnormal metabolic networks in atypical parkinsonism | 3.2 | 189 | Citations (PDF) |
| 156 | Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease | 2.0 | 49 | Citations (PDF) |
| 157 | Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease | 2.3 | 143 | Citations (PDF) |
| 158 | Dopaminergic Suppression of Brain Deactivation Responses during Sequence Learning | 2.3 | 67 | Citations (PDF) |
| 159 | Metabolic correlates of subthalamic nucleus activity in Parkinson's diseaseBrain, 2008, 131, 1373-1380 | 5.9 | 86 | Citations (PDF) |
| 160 | Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease | 0.7 | 223 | Citations (PDF) |
| 161 | Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease | 5.2 | 179 | Citations (PDF) |
| 162 | Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance studyBrain, 2007, 131, 146-154 | 5.9 | 101 | Citations (PDF) |
| 163 | Thalamic metabolism and symptom onset in preclinical Huntington's diseaseBrain, 2007, 130, 2858-2867 | 5.9 | 194 | Citations (PDF) |
| 164 | Relationship Between Self-reported Apathy and Executive Dysfunction in Nondemented Patients With Parkinson Disease | 0.6 | 84 | Citations (PDF) |
| 165 | L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease | 2.0 | 47 | Citations (PDF) |
| 166 | Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT | 2.4 | 64 | Citations (PDF) |
| 167 | Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study | 3.0 | 33 | Citations (PDF) |
| 168 | Metabolic brain networks associated with cognitive function in Parkinson's disease | 3.0 | 353 | Citations (PDF) |
| 169 | Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial | 46.9 | 1,027 | Citations (PDF) |
| 170 | Changes in network activity with the progression of Parkinson's diseaseBrain, 2007, 130, 1834-1846 | 5.9 | 402 | Citations (PDF) |
| 171 | Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging | 3.2 | 48 | Citations (PDF) |
| 172 | Gene transfer therapy for neurodegenerative disorders | 3.2 | 14 | Citations (PDF) |
| 173 | Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility | 3.1 | 327 | Citations (PDF) |
| 174 | Subthalamic Glutamic Acid Decarboxylase Gene Therapy: Changes in Motor Function and Cortical Metabolism | 3.1 | 133 | Citations (PDF) |
| 175 | The assessment of neurological systems with functional imaging | 1.1 | 10 | Citations (PDF) |
| 176 | Multivariate analysis: Applications to the study of hereditary movement disorders | 1.0 | 1 | Citations (PDF) |
| 177 | Assessment of the progression of Parkinson's disease: a metabolic network approach | 13.7 | 160 | Citations (PDF) |
| 178 | Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease | 1.6 | 56 | Citations (PDF) |
| 179 | Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease | 3.0 | 161 | Citations (PDF) |
| 180 | Functional imaging of sequence learning in Parkinson's disease | 1.2 | 47 | Citations (PDF) |
| 181 | An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease | 0.7 | 164 | Citations (PDF) |
| 182 | Preclinical Huntington's disease: Compensatory brain responses during learning | 4.6 | 113 | Citations (PDF) |
| 183 | Network modulation in the treatment of Parkinson's diseaseBrain, 2006, 129, 2667-2678 | 5.9 | 359 | Citations (PDF) |
| 184 | Quantification of Parkinson’s disease-related network expression with ECD SPECT | 4.0 | 74 | Citations (PDF) |
| 185 | The metabolic pathology of dopa-responsive dystonia | 4.6 | 64 | Citations (PDF) |
| 186 | A New Approach to Spatial Covariance Modeling of Functional Brain Imaging Data: Ordinal Trend Analysis | 1.1 | 124 | Citations (PDF) |
| 187 | Decreased striatal D2 receptor binding in non-manifesting carriers of the
DYT1
dystonia mutation | 0.7 | 159 | Citations (PDF) |
| 188 | FDG PET in the differential diagnosis of parkinsonian disorders | 3.0 | 421 | Citations (PDF) |
| 189 | Neuroimaging and therapeutics in movement disorders | 3.4 | 68 | Citations (PDF) |
| 190 | Functional neuroanatomy of non-verbal semantic sound processing in humans | 2.4 | 38 | Citations (PDF) |
| 191 | Abnormal covariance metabolic topography in patients with progressive supranuclear palsy: A FDG PET study | 3.1 | 0 | Citations (PDF) |
| 192 | A comparative F-dopa and FDG PET study of parkinsonian subjects without evidence of dopaminergic dysfunction | 3.1 | 0 | Citations (PDF) |
| 193 | Regional metabolism in primary torsion dystonia | 0.7 | 132 | Citations (PDF) |
| 194 | Assessment of disease progression in parkinsonism | 2.7 | 5 | Citations (PDF) |
| 195 | The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson?s disease and multiple system atrophy | 1.6 | 31 | Citations (PDF) |
| 196 | Microstructural white matter changes in carriers of the DYT1 gene mutation | 4.6 | 142 | Citations (PDF) |
| 197 | Executive processes in Parkinson's disease: FDG-PET and network analysis | 2.3 | 102 | Citations (PDF) |
| 198 | Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics | 3.0 | 86 | Citations (PDF) |
| 199 | Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism | 3.0 | 113 | Citations (PDF) |
| 200 | Differential Cortical and Subcortical Activations in Learning Rotations and Gains for Reaching: A PET Study | 1.4 | 234 | Citations (PDF) |
| 201 | Learning networks in health and Parkinson's disease: Reproducibility and treatment effects | 2.3 | 74 | Citations (PDF) |
| 202 | Early stage Parkinson's disease patients and normal volunteers: Comparative mechanisms of sequence learning | 2.3 | 44 | Citations (PDF) |
| 203 | Impaired sequence learning in carriers of the DYT1 dystonia mutation | 4.6 | 190 | Citations (PDF) |
| 204 | Enhancement of brain activation during trial-and-error sequence learning in early PD | 0.7 | 90 | Citations (PDF) |
| 205 | The differential effect of PD and normal aging on early explicit sequence learning | 0.7 | 112 | Citations (PDF) |
| 206 | Effects of levodopa on motor sequence learning in Parkinson’s disease | 0.7 | 91 | Citations (PDF) |
| 207 | Relationships Among the Metabolic Patterns That Correlate With Mnemonic, Visuospatial, and Mood Symptoms in Parkinson’s Disease | 5.1 | 150 | Citations (PDF) |
| 208 | Effects of levodopa infusion on motor activation responses in Parkinson’s disease | 0.7 | 37 | Citations (PDF) |
| 209 | Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography | 2.4 | 36 | Citations (PDF) |
| 210 | Pallidal stimulation for Parkinsonism: Improved brain activation during sequence learning | 4.6 | 51 | Citations (PDF) |
| 211 | Dyskinesia after fetal cell transplantation for parkinsonism: A PET study | 4.6 | 260 | Citations (PDF) |
| 212 | Primary dystonia: Is abnormal functional brain architecture linked to genotype? | 4.6 | 120 | Citations (PDF) |
| 213 | Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism | 3.2 | 90 | Citations (PDF) |
| 214 | Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease | 26.4 | 2,377 | Citations (PDF) |
| 215 | Functional brain networks in Parkinson's disease | 2.0 | 34 | Citations (PDF) |
| 216 | Oculogyric-like crises in a 92-year-old woman with vascular Parkinsonism | 3.2 | 7 | Citations (PDF) |
| 217 | Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease | 2.3 | 137 | Citations (PDF) |
| 218 | Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease | 4.6 | 79 | Citations (PDF) |
| 219 | Metabolic changes following subthalamotomy for advanced Parkinson's disease | 4.6 | 93 | Citations (PDF) |
| 220 | Functional correlates of pallidal stimulation for Parkinson's disease | 4.6 | 110 | Citations (PDF) |
| 221 | Reply to "Transplanted dopaminergic neurons: More or less?" | 22.6 | 31 | Citations (PDF) |
| 222 | Metabolic correlates of levodopa response in Parkinson’s disease | 0.7 | 170 | Citations (PDF) |
| 223 | Functional brain imaging of movement disorders | 1.1 | 31 | Citations (PDF) |
| 224 | Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration | 3.2 | 32 | Citations (PDF) |
| 225 | Patterns of regional brain activation associated with different forms of motor learning | 1.9 | 357 | Citations (PDF) |
| 226 | The metabolic topography of essential blepharospasm | 0.7 | 166 | Citations (PDF) |
| 227 | PET Applications to Surgical Treatment of Parkinson's Disease | 0.0 | 0 | Citations (PDF) |
| 228 | Increased anterior cingulate and caudate activity in bipolar mania | 3.8 | 270 | Citations (PDF) |
| 229 | Radiosynthesis of [] N-3-fluoropropyl-2-β-carbomethoxy-3-β(4′ methylphenyl) nortropane (FPCMT) | 1.4 | 16 | Citations (PDF) |
| 230 | [11C]Raclopride-PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length | 4.6 | 126 | Citations (PDF) |
| 231 | Functional brain networks in DYT1 dystonia | 4.6 | 314 | Citations (PDF) |
| 232 | Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET | 3.2 | 106 | Citations (PDF) |
| 233 | Arm tremor secondary to Wilson's disease | 3.2 | 11 | Citations (PDF) |
| 234 | Quantitative Brain PET Comparison of 2D and 3D Acquisitions on the GE Advance Scanner | 0.7 | 46 | Citations (PDF) |
| 235 | The metabolic anatomy of tremor in Parkinson's disease | 0.7 | 111 | Citations (PDF) |
| 236 | Nervous system dysfunction in Waldenström's macroglobulinemia: Response to treatment | 0.7 | 52 | Citations (PDF) |
| 237 | Cognitive functioning after pallidotomy for refractory Parkinson's disease | 4.2 | 50 | Citations (PDF) |
| 238 | Cerebral Glucose Metabolism in Women With Panic Disorder | 5.1 | 124 | Citations (PDF) |
| 239 | Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageingBrain, 1997, 120, 2197-2206 | 5.9 | 62 | Citations (PDF) |
| 240 | Metabolic correlates of pallidal neuronal activity in Parkinson's diseaseBrain, 1997, 120, 1315-1324 | 5.9 | 122 | Citations (PDF) |
| 241 | Preoperative indicators of clinical outcome following stereotaxic pallidotomy | 0.7 | 59 | Citations (PDF) |
| 242 | Stereotactic pallidotomy for Parkinson's disease | 0.7 | 114 | Citations (PDF) |
| 243 | The metabolic anatomy of Tourette's syndrome | 0.7 | 166 | Citations (PDF) |
| 244 | Imipenem-induced myoclonus | 3.2 | 15 | Citations (PDF) |
| 245 | Surgical therapies for parkinson's disease: Embryonic nigral grafts and pallidal ablation | 3.8 | 0 | Citations (PDF) |
| 246 | The Metabolic Topography of Normal Aging | 3.1 | 266 | Citations (PDF) |
| 247 | Fluorodopa Positron Emission Tomography with an Inhibitor of Catechol-O-Methyltransferase: Effect of the Plasma 3-O-Methyldopa Fraction on Data Analysis | 3.1 | 54 | Citations (PDF) |
| 248 | Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations | 0.7 | 43 | Citations (PDF) |
| 249 | The metabolic topography of idiopathic torsion dystoniaBrain, 1995, 118, 1473-1484 | 5.9 | 170 | Citations (PDF) |
| 250 | Visualizing the evolution of abnormal metabolic networks in the brain using PET | 3.3 | 23 | Citations (PDF) |
| 251 | Stereotactic ventral pallidotomy for Parkinson's disease | 0.7 | 432 | Citations (PDF) |
| 252 | Dementia associated with bilateral carotid occlusions: neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery. | 4.2 | 65 | Citations (PDF) |
| 253 | Early differential diagnosis of Parkinson's disease with
18
F‐fluorodeoxyglucose and positron emission tomography | 0.7 | 158 | Citations (PDF) |
| 254 | Cerebral metabolic topography in unilateral temporal lobe epilepsy | 0.7 | 56 | Citations (PDF) |
| 255 | Quantitative brain FDG/PET studies using dynamic aortic imaging | 2.0 | 17 | Citations (PDF) |
| 256 | A disposable synthetic unit for the preparation of 3-O-methyl-6-[18F]fluorodopa using a regioselective fluorodemercuration reaction | 1.4 | 7 | Citations (PDF) |
| 257 | The Metabolic Topography of Parkinsonism | 3.1 | 450 | Citations (PDF) |
| 258 | Alternating hemichorea in primary antiphospholipid syndrome | 0.7 | 66 | Citations (PDF) |
| 259 | Metabolic topography of the hemiparkinsonism‐hemiatrophy syndrome | 0.7 | 29 | Citations (PDF) |
| 260 | Synthesis of 6-[18F]fluorodopamine with a synthetic unit made up of primarily sterile disposable components and operated by a master slave manipulator | 1.4 | 18 | Citations (PDF) |
| 261 | Striatal
18
F-DOPA Uptake: Absence of an Aging Effect | 3.1 | 93 | Citations (PDF) |
| 262 | Superpett 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation | 1.3 | 23 | Citations (PDF) |
| 263 | Imaging cerebral function | 0.4 | 32 | Citations (PDF) |
| 264 | Positron Emission Tomography Studies in Parkinsonism | 2.0 | 38 | Citations (PDF) |
| 265 | The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. | 4.2 | 193 | Citations (PDF) |
| 266 | Waht is it? Case 1, 1990: Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb | 3.2 | 25 | Citations (PDF) |
| 267 | Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease | 6.8 | 270 | Citations (PDF) |
| 268 | ADULT ONSET HALLERVORDEN-SPATZ DISEASE WITH NEUROFIBRILLARY PATHOLOGYBrain, 1987, 110, 993-1013 | 5.9 | 82 | Citations (PDF) |
| 269 | Polyradiculoneuropathy, polyradiculitis, and CMV in AIDS and ARC | 0.7 | 0 | Citations (PDF) |
| 270 | Thrombotic cerebral vasculopathy associated with herpes zoster | 4.6 | 184 | Citations (PDF) |
| 271 | Progressive polyradiculopathy in acquired immune deficiency syndrome | 0.7 | 190 | Citations (PDF) |
| 272 | Inferior Parietal Lobule | 6.8 | 370 | Citations (PDF) |
| 273 | Symmetry and Asymmetry in the Human Posterior Thalamus | 6.8 | 132 | Citations (PDF) |
| 274 | Symmetry and Asymmetry in the Human Posterior Thalamus | 6.8 | 92 | Citations (PDF) |
| 275 | Title is missing! 0 | | 1 | Citations (PDF) |
| 276 | Imaging of Disease-Related Networks in Parkinson's Disease | 2.9 | 4 | Citations (PDF) |
| 277 | Utility of [
18
F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging | 1.7 | 0 | Citations (PDF) |
